Although our understanding of the pathogenesis of Type 1 (insulin-dependent) diabetes is increasing, vital information is still lacking which would help us to identify individuals at risk and to prevent or postpone the onset of the disease. Since only 30-50 % of identical twins are concordant for Type 1 diabetes [1] , environmental factors seem to be of substantial pathogenic importance. The prospective recording of cases is necessary to provide the basis for case-control studies concerning pathogenic factors. The incidence of Type i diabetes in children and young adults is high in the Scandinavian countries [2] [3] [4] [5] [6] [7] . The population in Sweden is stable and ethnically quite homogeneous and the health care system is well-organized and offers unique opportunities for epidemiological studies [8, 9] .
Since 1 January 1983, all newly-diagnosed young adult diabetic subjects in the 15-34-year age group have been recorded in the Swedish Young Adults Diabetes Register [7" ]. We decided to make a cut-off point at 35 years of age as we are mainly interested in Type 1 diabetes in young adults. This decision was also based on the supposition that almost all diabetic patients under the age of 35 years are being treated in departments of internal medicine in Sweden which use the same guidelines for classification and treatment.
This paper summarizes and discusses the results of the first 5 years of this ongoing prospective study. It is particularly concerned with age, sex, type of diabetes, body mass index, percent desirable weight and blood glucose level at the time of diagnosis.
Subjects and methods
A standardized registration form was designed for this investigation. The study has been conducted on a nationwide basis in collaboration with all departments of internal medicine (n = 96), endocrinology (n = 2), paediatrics (n = 44), obstetrics and gynaecology (n = 75) and approximately 710 primary health care units.
There are six public health regions in Sweden, each with one university hospital which is responsible for the medical service. For the present study six diabetologists served as contact persons for their respective regional medical institutions. All departments and health care units had a physician who was responsible for the recording procedure. The study was brought to the attention of the physi- As regards diagnostic criteria, the physician completing the registration form was asked to consider the following alternatives: (1) fasting blood glucose > 7.0 mmol/l and/or random blood glucose > 10.0 mmol/l; (2) fasting blood glucose < 7.0 retool/1 and impaired glucose tolerance; (3) fasting blood glucose < 7.0 mmol/l and oral glucose tolerance test (OGTr) not performed. The third alternative was designed for patients considered to have diabetes on the grounds of an earlier history of the disease -for example, gestational diabetes -where the physicians concluded that a slightly elevated blood glucose concentration did not call for an OGTT to verify the diagnosis. A total of 93 %, 6 % and 1% of the reported cases were registered according to alternatives 1, 2 and 3, respectively. Thus, only a few cases (n = 20) in this large cohort had a diagnosis which was not clearly verified. All patients classified according to alternatives 2 and 3 were considered as Type 2 diabetic subjects.
A study of the validity of the registration was conducted by use of the Patient Administration System (PAS-IC) [11] , which is a computer-based system for registering the hospital admittance and care of in-patients. This validity study was performed in the counties of Malm6hus and Kristianstad in the south of Sweden, which have 9.2% of the Swedish 15-34-year-old population. Since there was a possibility that patients might have been missed by both systems and registers, we used the methodology based on the principle of the two-sample capture-recapture phenomenon [12] . In this validity test, a quite high detection level was found for Type 1 diabetes = 0.86. For Type 1 and Type 2 diabetes taken together, the detection level was 0.79 with no difference between the genders. Since the ascertainment of newly-diagnosed diabetic cases is not known for the other counties in Sweden no correction of the primary incidence data has been performed.
The study was approved by the Ethics Committee of the Karolinska Institute in Stockholm. Permission to use the Swedish national civic registration number in our data base was granted by the Swedish Inspection Board.
Statistical analysis
Data were collected and analysed in the Department of Epidemiology and Health Care Research, Ume~t. Population data from the publications of "Statistics, Sweden", were used to calculate age-and sex-specific incidences. Incidence rates (per 100000 and year) and 95 % confidence intervals were calculated. The Student's t-test was used to determine whether the difference between the sexes was due to chance.
Results
A total of 1,214 male and 720 female cases of newly-diagnosed, but not gestational, diabetes were reported in the 15-34-year age group in Sweden during the period 1983-1987 (Table 1) . The populations at risk were 1,189, 101 males and 1,137,739 females. The incidence was significantly higher (p < 0.001) in males (20.5/100,000/year) than in females (12.7/100,000/year). Among males, 77.4 % were classified as Type 1 and 15.2 % as Type 2 diabetic Number of patients investigated in parentheses subjects, and 4.9 % were not classifiable. The correspond-400 ing figures for females were 67.4 %, 18.9 % and 11.3 %, respectively. The incidence of Type 2 diabetes was slightly ~ 300 higher in males, but not significantly so. Only a few pao 20o tients had secondary diabetes (n --49) with the majority "~ being in the 30-34 year age group. Pancreatitis was the _~ ~00 most common underlying disease, but a number of other disorders were present, such as Cushing's syndrome, acroz 0 megaly, glucagonoma, pancreatic carcinoma and the @ Prader-Willi syndrome. (Fig. 1 a) . The findings in females were essentially the same, 88.6 % and 33.3 %, respectively (Fig. i b) . The mean maximum blood glucose level was significantly higher (23.0 mmol/1) in males with Type i diabetes than in males with Type 2 diabetes (15.2 retool/l) (p < 0.0001) ( Table 2 ). The corresponding figures in females were 21.6 mmol/1 (Type 1) and 13.6 retool/1 (Type 2), respectively (p < 0.001). Thus, the maximum blood glucose levels at diagnosis were higher in males than in females, irrespective of the type of diabetes.
A body mass index exceeding 25 kg/m 2 at diagnosis was reported in 11.8 % of males and 12.0 % of females, classis0c fled as having Type I diabetes (Fig. 2 a, b) , and in as many ,0~ as 63.8 % of males and 64.6 % of females with Type 2 diabetes. PDW was significantly higher in females, with ~ ~ 30c both Type i (p < 0.0001) and Type 2 diabetes (p < 0.003) ( Table 2) .
~ 2oc Among patients classified as having Type 1 diabetes ~ ,0c 90.6 % were diagnosed as a result of clinical symptoms, whereas the corresponding figure for patients classified as Type 2 diabetic subjects was 54.9 %. Thus, almost half of @ the patients classified as Type 2 diabetic subjects were diagnosed in connection with a general examination because of ill-defined symptoms or as part of a health checkup. 
Discussion
This prospective ongoing incidence study of diabetes in the 15-34-year age group in Sweden was conducted on a nationwide basis and involved physicians in more than 100 hospital departments and in more than 700 primary health care units. For efficient co-operation, the recording of cases was made as simple as possible with regard to diagnostic procedure/criteria that are generally accepted in Sweden. Our diagnostic criteria may be compared with those established by the World Health Organisation (WHO) in 1979 [13] , WHO in 1985 [14], Teuscher and Jarrett [15] and the National Diabetes Data Group (NDDG) [10] which require a fasting venous or capillary whole blood glucose concentration of >7.0, _>6.7, >7.0 and > 6.7 mmol/1, respectively, and/or _> 10.0 mmol/1 for venous blood or > 11.1 mmol/1 for capillary whole blood after a 75 g oral glucose load. An insignificant number of individuals reported as Type 2 diabetic subjects with borderline values may not have fulfilled strict diagnostic criteria, using a standardized glucose tolerance test and a strict analytical procedure throughout the country. The finding that only a very small number of subjects had a maximum blood glucose of < 10.0 mmol/1 supports the view that the risk of over-reporting was low.
Concerning the risk of under-reporting, a quite high detection level (0.86) was found for Type 1 diabetes. Since our study is ongoing and diabetes is a chronic disease for which the responsible physicians are repeatedly asked to check their records, some patients who may have been initially overlooked can be expected to be reported later on, so that the risk of under-reporting will gradually decrease. Type 2 diabetes was detected during an asymptomatic period in about 50% of the patients. This type of casefinding is more developed in some primary health care units than in others, which indicates that significant underreporting is likely. Our conclusion is that the incidence data reported in this study are minimal rates and that the true figures may be 10 % higher for Type i diabetes and 20 % higher for Type 2 diabetes, particularly in patients over the age of 30 years.
At diagnosis in some cases it may be difficult or impossible to classify the type of diabetes. Thus, in some non-obese patients with initial mild hyperglycaemia progressing to insulin-dependency after some months or years, it is uncertain whether they should be classified as Type 1 with slow onset or as Type 2 subjects [17, 18] . When the NDDG criteria [10] were applied to some hundreds of diabetic patients, more than one third could not be classified as either Type 1 or Type 2 diabetic subjects [19] . In the present study, in which the classification was based on the clinical experience of the reporting physician, a certain degree of misclassification may be expected. The distribution curves also show an overlapping of maximum blood glucose levels and body mass indexes, although the mean values differ significantly between subjects classified as Type i and Type 2 diabetic patients. This report covers the first 5 years of a prospective ongoing study in Sweden. We have now included the measurement of islet-cell antibodies, HLA-DQ polymorphism and C-peptide at diagnosis to further characterize these young diabetic subjects. This will be reported at a later stage. Until we have more accurate and independent methods of identifying patients in certain groups our classification of young adult diabetic patients at Type 1 or Type 2 will be only approximate.
The total incidence of diabetes in Sweden in the 15-34-year age group was high throughout the study period, with a moderate year-to-year variation. The mean annual incidence (per 100,000) was 20.5 for males and 12.7 for females. When our incidence rates were restricted to reported Type 1 diabetic subjects we found the incidence to be 15.9 for males and 8.6 for females and in the 15-19-year age group, 18.2 and 11.4, respectively. The previously reported incidence data in the literature are summarized in Table 3 [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . This shows that the recent incidence rate in Sweden is lower than those reported in Finland [28] and recently in Scotland, UK [29] , but higher than previously reported in Oslo [20, 21] , Allegheny, USA [22, 23] , New Zealand [24] , Scotland, UK [25] , Denmark [26] , Wisconsin, USA [28] , The Netherlands [30] , Alabama, USA [31] , Kuwait [32] , Lombardy, Italy [33] and Oxford, UK [34] . Only a limited number of studies, usually retrospective, have been undertaken in the 20-35 year age group namely in Oslo [20, 21] , Denmark [26] and Wisconsin, USA [28] . The current incidence of diabetes in Sweden was significantly higher than in those studies. However, it was considerably lower than in the 20-29-year age group in Kuwait, which has the highest incidence rate so far reported in the world 71.5 in males and 94.0 in females. More than two thirds of these patients were on diet treatment alone or on oral hypoglycaemic drugs. It is not known whether the third of the patients who were treated with insulin had Type 1 or Type 2 diabetes.
The male predominance reported in the first year of this study [7] was also noted in the 5-year study, with an overall male-to-female ratio of 1.6:1 and 1.8 : 1 for those G. Blohm6 et al.: Male predominance in Type 1 (insulin-dependent) diabetes mellitus reported with Type 1 diabetes. The initial maximum blood glucose level was significantly higher in males than in females, regardless of the type of diabetes. Moreover, PDW at diagnosis was lower in males with Type i or Type 2 diabetes. The percentages of males and females classified as having Type 2 diabetes, on the grounds of clinical symptoms, were almost the same. Thus, it seems likely that males with Type 2 diabetes were not miselassified as Type i diabetic subjects to a greater extent than females. There is no clear explanation as to why males with Type 1 diabetes had a higher blood glucose level and a lower PDW at diagnosis. One interpretation may be that males wait longer before they go to see a doctor or that the destruction of the Beta cells is more rapid. The possibility that either Type I or Type 2 diabetes had been incorrectly diagnosed as gestational diabetes might explain the high male-to-female ratio has been discussed previously [7] . Thus, analyses of the first-year data showed that females recorded as having gestational diabetes had normal or only slightly elevated blood glucose levels which norrealized after delivery without anti-diabetic treatment. An incorrect diagnosis of gestational diabetes therefore only accounted for a very small, if any, difference in incidence between males and females. Furthermore, in the present study the sex ratio was the same in the 15-19-year age group, in which practically no patients with gestational diabetes were reported, as in the three older age groups.
Concerning the male predominance this has been previously observed, even if it was less marked than in the present study, in the 15-19-year age group in a number Of studies, for example Oslo [21] , Allegheny, USA [22, 23] , Scotland, UK [25] , Finland [27] , Wisconsin, USA [28] , The Netherlands [30] and Lombardy, Italy [33] . The reason why this has not been previously emphasized may be that the number of cases in these studies, except in Finland [27] , Scotland, UK [29] and The Netherlands [30] , was rather small and no attempt was made to examine possible errors underlying the observed sex differences.
The high male-to-female ratio is apparently not obvious until the post-pubertal years; it starts between 13 and 14 years, before which age there is a similar incidence in both sexes [2] [3] [4] [5] . The increase in the male-tofemale ratio after puberty indicates that sex hormones may have an impact on the incidence of diabetes. An increased susceptibility to viral and bacterial infections may be one explanation. It has been shown that sex differences -with male predominance -occur in the incidence of mumps [35] , Coxsaekie B virus [35] [36] [37] , adenovirus [38] , echovirus [35, 39] and polio virus [35] infections in children. It has been hypothesized that differences in susceptibility to infections may be related to a Y-linked histocompatibility locus [39] . However, no male predominance was found in adults [36, 37] . No difference in the frequency of IgM antibodies against Coxsackie B virus serotypes has been found in two recent studies performed in children with newly-diagnosed Type I diabetes [40, 41] . The importance of virus infections for the development of Type i diabetes is still uncertain [42] , and the present finding of male predominance does not allow any conclusions to be drawn concerning increased suscepti-bility to virus infections in males. Differences in the lifestyle of males may also have an impact on the incidence of diabetes and the findings call for further studies in this respect. This may explain why Type 1 diabetes is more common in males, despite the fact that this disease is associated with other autoimmune diseases showing a significant female predominance, such as thyroid diseases [43, 44] . In this connection it is of interest that a higher male incidence of Type 1 diabetes has been noted in Germany [45] starting at the age of 25-30 years and including the 50-55-year-age group (Michaelis D: personal communication). Further studies on the aetiology of Type 1 diabetes should take into consideration the finding that the male predominance that is seen after puberty, appears to gradually increase.
